Tuncer, I. Et Al. 2003. Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat - The effect of AT1-R blocker on the hepatic fibrosis. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY , vol.55 , 159-166.

Tuncer, I., Ozbek, H., Ugras, S., & Bayram, I., (2003). Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat - The effect of AT1-R blocker on the hepatic fibrosis. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY , vol.55, 159-166.

Tuncer, I Et Al. "Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat - The effect of AT1-R blocker on the hepatic fibrosis," EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY , vol.55, 159-166, 2003

Tuncer, I Et Al. "Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat - The effect of AT1-R blocker on the hepatic fibrosis." EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY , vol.55, pp.159-166, 2003

Tuncer, I. Et Al. (2003) . "Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat - The effect of AT1-R blocker on the hepatic fibrosis." EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY , vol.55, pp.159-166.

@article{article, author={I Tuncer Et Al. }, title={Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat - The effect of AT1-R blocker on the hepatic fibrosis}, journal={EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY}, year=2003, pages={159-166} }